catechin has been researched along with Cognition Disorders in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (14.81) | 29.6817 |
| 2010's | 20 (74.07) | 24.3611 |
| 2020's | 3 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Funayama, S; Izuo, N; Kim, J; Shimizu, T | 1 |
| Ahn, JW; Chae, HK; Chung, S; Jang, WS; Jeong, JH; Kim, S; Kim, YH; Ko, S | 1 |
| Fan, J; Nan, S; Wang, P; Zhang, Y | 1 |
| Hong, H; Li, Y; Su, B | 1 |
| Actis-Goretta, L; Haskell-Ramsay, CF; Schmitt, J | 1 |
| Cortés, MJ; Cuenca-Royo, A; de la Torre, R; de Sola, S; Del Hoyo, L; Dierssen, M; Espadaler, JM; Esteba, S; Farré, M; Gomis-González, M; Hernandez, G; Langohr, K; León, A; Martínez-Leal, R; Milá, M; Novell, R; Ozaita, A; Rodriguez, J; Sánchez-Gutiérrez, J; Xicota, L | 1 |
| Ashafaq, M; Ejaz Ahmed, M; Islam, F; Javed, H; Khan, A; Khan, MM; Safhi, MM; Tabassum, R; Vaibhav, K | 1 |
| Akagawa, K; Fujii, H; Fujiwara, T; Izawa, T; Kitadate, K; Kizaki, T; Nishioka, H; Ogasawara, J; Ohno, H; Sakurai, T; Sato, S | 1 |
| Cheng, Y; Duan, Y; Fan, R; He, Y; Sun, G; Sun, X; Wang, Z; Zhang, H | 1 |
| Cho, EJ; Choi, YY; Fujii, H; Kim, HY; Maeda, T; Shibamoto, T; Yokozawa, T | 1 |
| Heo, HJ; Jeong, JH; Jin, DE; Kim, HJ; Kwon, OJ; Park, SK | 1 |
| Chang, X; Chen, Y; Cheng, S; Dun, W; Fang, S; Gu, X; He, W; Hou, X; Hu, Q; Liu, S; Mo, Y; Rong, C; Su, R; Wang, Q; Yang, C; Zhang, C; Zhang, L | 1 |
| Abeysekera, I; Dria, KJ; Goodlett, CR; Roper, RJ; Stringer, M | 1 |
| Cho, WJ; Han, JY; Jung, YD; Kim, JH; Kim, JK; Lee, SG; Oh, BS | 1 |
| Benejam, B; Blanco-Hinojo, L; Bléhaut, H; Catuara-Solarz, S; Cuenca-Royo, A; de la Torre, R; de Sola, S; Del Hoyo, L; Delabar, JM; Dierssen, M; Dueñas-Espín, I; Espadaler, JM; Farré, M; Fitó, M; Hernandez, G; Janel, N; Langohr, K; Principe, A; Pujol, J; Rodriguez, J; Sanchez-Benavides, G; Videla, S; Xicota, L | 1 |
| Kim, J; Lee, HJ; Lee, KW | 1 |
| Chopra, K; Kuhad, A; Tiwari, V | 1 |
| Abraham, NG; Calogero, C; Caruso, C; Fabio, G; Nader, AG; Scapagnini, G; Sonya, V; Vasto, S; Zella, D | 1 |
| Hashimoto, S; Imano, M; Ito, A; Itoh, T; Nishida, S; Satou, T; Tsubaki, M | 1 |
| Feng, L; Liu, F; Song, J; Xu, H | 1 |
| Gomez-Pinilla, F; Nguyen, TT | 1 |
| Nehlig, A | 1 |
| Choi, SJ; Heo, HJ; Jeong, HR; Jeong, JH; Jin, DE; Jo, YN; Shin, DH; Song, BG | 1 |
| Kishido, T; Oku, N; Takabayashi, F; Unno, K | 1 |
| Choba, D; Fukutomi, R; Hoshino, M; Kikunaga, N; Kishido, T; Oku, N; Takabayashi, F; Unno, K; Yoshida, H | 1 |
| Barnes, S; Ferruzzi, MG; Janle, EM; Kim, H; Lila, MA; Morré, DJ; Morré, DM; Simon, JE; Weaver, CM; Wyss, JM | 1 |
| Arendash, GW; Fernandez, F; Hou, H; Jensen, M; Rezai-Zadeh, K; Runfeldt, M; Shytle, RD; Tan, J | 1 |
7 review(s) available for catechin and Cognition Disorders
| Article | Year |
|---|---|
The Impact of Epicatechin on Human Cognition: The Role of Cerebral Blood Flow.
Topics: Cacao; Catechin; Cerebrovascular Circulation; Chocolate; Cognition; Cognition Disorders; Executive Function; Humans; Memory; Plant Extracts; Reaction Time | 2018 |
Naturally occurring phytochemicals for the prevention of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Catechin; Cognition Disorders; Curcumin; Dietary Supplements; Humans; Oxidative Stress; Phytotherapy; Plant Extracts; Resveratrol; Stilbenes | 2010 |
Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders.
Topics: Animals; Antioxidants; Catechin; Cognition Disorders; Curcumin; Diet; Food; Heme Oxygenase-1; Humans; Molecular Structure; Neurodegenerative Diseases; Neuroprotective Agents; NF-E2-Related Factor 2; Polyphenols; Response Elements | 2011 |
Tea and cognitive health in late life: current evidence and future directions.
Topics: Aged; Camellia sinensis; Catechin; Cognition; Cognition Disorders; Dementia; Glutamates; Humans; Neuroprotective Agents; Phytotherapy; Plant Extracts; Tea | 2012 |
Natural mood foods: the actions of polyphenols against psychiatric and cognitive disorders.
Topics: Affect; Animals; Antioxidants; Brain; Catechin; Cognition Disorders; Curcumin; Diet; Energy Intake; Energy Metabolism; Food Preferences; Humans; Nervous System Physiological Phenomena; Neurodegenerative Diseases; Oxidative Stress; Polyphenols | 2012 |
The neuroprotective effects of cocoa flavanol and its influence on cognitive performance.
Topics: Aging; Alzheimer Disease; Animals; Antioxidants; Brain; Cacao; Catechin; Cognition; Cognition Disorders; Flavonoids; Humans; Neurogenesis; Neuroprotective Agents; Rats; Stroke | 2013 |
Botanicals for age-related diseases: from field to practice.
Topics: Aging; Antioxidants; Biological Availability; Blood Vessels; Bone Resorption; Catechin; Cognition; Cognition Disorders; Flavonoids; Health; Humans; Neoplasms; Oxidative Stress; Phenols; Polyphenols | 2008 |
2 trial(s) available for catechin and Cognition Disorders
| Article | Year |
|---|---|
A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome.
Topics: Adult; Animals; Catechin; Cognition Disorders; Disease Models, Animal; Double-Blind Method; Female; Fragile X Syndrome; Humans; Male; Mice; Mice, Knockout; Middle Aged; Neuroprotective Agents; Treatment Outcome; Young Adult | 2020 |
Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial.
Topics: Adaptation, Psychological; Adult; Catechin; Cholesterol; Cognition Disorders; Cognitive Behavioral Therapy; Double-Blind Method; Down Syndrome; Female; Follow-Up Studies; Homocysteine; Humans; Inhibition, Psychological; Male; Neuroprotective Agents; Recognition, Psychology; Retrospective Studies; Spain; Treatment Outcome; Young Adult | 2016 |
18 other study(ies) available for catechin and Cognition Disorders
| Article | Year |
|---|---|
Dietary supplementation of a high-temperature-processed green tea extract attenuates cognitive impairment in PS2 and Tg2576 mice.
Topics: Amyloid beta-Peptides; Animals; Camellia sinensis; Catechin; Cognition Disorders; Dietary Supplements; Hot Temperature; Mice; Mice, Transgenic; PC12 Cells; Plant Extracts; Presenilin-2; Rats | 2019 |
(-)-Gallocatechin gallate from green tea rescues cognitive impairment through restoring hippocampal silent synapses in post-menopausal depression.
Topics: Animals; Antioxidants; Catechin; Cognition Disorders; Cognitive Dysfunction; Depression; Dietary Supplements; Female; Hippocampus; Plant Extracts; Postmenopause; Rats; Rats, Sprague-Dawley; Synapses; Tea | 2021 |
Epigallocatechin-3-Gallate Provides Protection Against Alzheimer's Disease-Induced Learning and Memory Impairments in Rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Antioxidants; Aspartic Acid Endopeptidases; Catechin; Cognition Disorders; Dose-Response Relationship, Drug; Hippocampus; Male; Maze Learning; Memory Disorders; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Sprague-Dawley; Spatial Memory; tau Proteins | 2021 |
Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Biomarkers; Catechin; Cell Line, Tumor; Cognition Disorders; Disease Models, Animal; Gene Expression Regulation; Humans; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; MicroRNAs; Mutation; Neuroblastoma; Presenilin-1; Protease Inhibitors; RNA, Messenger | 2017 |
Amelioration of cognitive impairment and neurodegeneration by catechin hydrate in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Behavior, Animal; Catechin; Choline O-Acetyltransferase; Cognition Disorders; Disease Models, Animal; Glutathione; Hippocampus; Interleukin-1beta; Male; Maze Learning; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Streptozocin; Tumor Necrosis Factor-alpha | 2013 |
Oligomerised lychee fruit-derived polyphenol attenuates cognitive impairment in senescence-accelerated mice and endoplasmic reticulum stress in neuronal cells.
Topics: Aging; Alzheimer Disease; Animals; Catechin; Cognition Disorders; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Fruit; Heat-Shock Proteins; Hippocampus; Litchi; Male; Membrane Proteins; Memory; Memory Disorders; Mice; Mice, Inbred Strains; Neurons; Phenols; Phytotherapy; Plant Extracts; Polyphenols; RNA, Messenger | 2013 |
Extremely low frequency electromagnetic field exposure causes cognitive impairment associated with alteration of the glutamate level, MAPK pathway activation and decreased CREB phosphorylation in mice hippocampus: reversal by procyanidins extracted from t
Topics: Animals; Biflavonoids; Catechin; Cognition Disorders; CREB-Binding Protein; Glutamic Acid; Hippocampus; Humans; Lotus; Male; MAP Kinase Signaling System; Mice; Mice, Inbred ICR; Phosphorylation; Plant Extracts; Proanthocyanidins | 2014 |
Oligonol improves memory and cognition under an amyloid β(25-35)-induced Alzheimer's mouse model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Awareness; Brain; Catechin; Cognition; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Fruit; Kidney; Lipid Peroxidation; Liver; Male; Maze Learning; Memory; Memory Disorders; Mice, Inbred ICR; Nitric Oxide; Peptide Fragments; Phenols; Phytotherapy; Plant Extracts; Recognition, Psychology | 2014 |
An investigation into the ameliorating effect of black soybean extract on learning and memory impairment with assessment of neuroprotective effects.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Animals; Antioxidants; Biflavonoids; Brain; Catechin; Cell Survival; Cognition Disorders; Glycine max; Learning; Learning Disabilities; Male; Memory; Memory Disorders; Mice, Inbred ICR; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Peptide Fragments; Phytotherapy; Plant Extracts; Polyphenols; Proanthocyanidins; Rats; Seeds | 2014 |
(-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression.
Topics: Alzheimer Disease; Animals; Catechin; Cell Proliferation; Cells, Cultured; CHO Cells; Cognition Disorders; Cricetulus; Disease Models, Animal; Mice; Neprilysin; Stereoisomerism; Up-Regulation | 2015 |
Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model.
Topics: Aging; Animals; Behavior, Animal; Brain Chemistry; Catechin; Cognition Disorders; Down Syndrome; Dyrk Kinases; Female; Growth; Learning; Maze Learning; Mice; Mice, Transgenic; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Recognition, Psychology | 2015 |
Neurorestorative effects of epigallocatechin-3-Gallate on cognitive function in a chronic cerebral hypoperfusion rat model.
Topics: Animals; Brain-Derived Neurotrophic Factor; Catechin; Cerebrovascular Disorders; Cognition Disorders; Disease Models, Animal; Drug Administration Routes; Escape Reaction; Hippocampus; Male; Malondialdehyde; Maze Learning; Neuroprotective Agents; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Superoxide Dismutase; Vascular Endothelial Growth Factor A | 2016 |
Epigallocatechin-3-gallate ameliorates alcohol-induced cognitive dysfunctions and apoptotic neurodegeneration in the developing rat brain.
Topics: Animals; Animals, Newborn; Apoptosis; Brain; Catechin; Cognition Disorders; Ethanol; Male; Maze Learning; Neurodegenerative Diseases; Random Allocation; Rats; Rats, Wistar | 2010 |
(-)-Epigallocatechin-3-gallate protects against neuronal cell death and improves cerebral function after traumatic brain injury in rats.
Topics: Animals; Apoptosis; Brain Injuries; Catechin; Cerebral Cortex; Cognition Disorders; DNA, Single-Stranded; Lipid Peroxidation; Male; Malondialdehyde; Neurons; Neuroprotective Agents; Rats; Rats, Wistar; Tea | 2011 |
Antiamnesic effects of ethyl acetate fraction from chestnut (Castanea crenata var. dulcis) inner skin on Aβ(25-35)-induced cognitive deficits in mice.
Topics: Acetates; Alzheimer Disease; Amyloid beta-Peptides; Animals; Catechin; Cell Survival; Chromatography, High Pressure Liquid; Cognition Disorders; Fagaceae; Fluoresceins; Gallic Acid; Hydrogen Peroxide; L-Lactate Dehydrogenase; Learning; Male; Memory; Mice; Mice, Inbred ICR; Neurons; Oxidative Stress; PC12 Cells; Plant Extracts; Rats; Reactive Oxygen Species | 2012 |
Suppressive effect of green tea catechins on morphologic and functional regression of the brain in aged mice with accelerated senescence (SAMP10).
Topics: Aging; Aging, Premature; Animals; Atrophy; Brain; Catechin; Cognition Disorders; DNA Damage; Female; Learning; Male; Memory; Mice; Neuropsychological Tests; Organ Size; Oxidative Stress; Phytotherapy; Plant Extracts; Tea | 2004 |
Daily consumption of green tea catechin delays memory regression in aged mice.
Topics: Aging; Animals; Antioxidants; Atrophy; Brain; Camellia sinensis; Catechin; Cellular Senescence; Cognition Disorders; DNA Damage; Learning; Male; Memory; Mice; Mice, Inbred Strains; Models, Animal; Oxidative Stress; Plant Extracts | 2007 |
Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Catechin; Cognition Disorders; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Maze Learning; Mice; Mice, Transgenic; Mutation; Neuroprotective Agents; Phosphorylation; tau Proteins | 2008 |